PubMed · 2000 · 343 citations · 14 references
MedicineMolecular MedicineOncologyMetastasisMolecular OncologyMolecular VirologyCancer BiomarkersCancer Molecular DiagnosticsCancer Survival AnalysisCirculating Tumor Dna AnalysisMalignant NeoplasmsNasopharyngeal CancerDisease PrognosticationEpstein-barr Virus - Associated MalignanciesMann - Whitney U TestOutcome PrognosticationPrognostic IndicesQuantitative Pcr DetectionReal-time Polymerase Chain Reaction (Pcr)Relative Risk Estimation
We investigated the prognostic implication of pretreatment plasma/serum EBV DNA concentration, as measured by real-time quantitative PCR, in nasopharyngeal carcinoma (NPC). In 91 prospectively recruited NPC patients, those with recurrence or metastasis within the first year after treatment had a higher median plasma EBV DNA concentration than those without events (41,756 copies/ml versus 5,807 copies/ml; P < 0.001, Mann-Whitney rank-sum test). In multivariate logistic regression analysis, plasma EBV DNA was an independent prognostic indicator for early clinical events [relative risk = 3.8 (95% confidence interval, 1.6-9.2 for each 10-fold increase in plasma EBV DNA concentration; P = 0.003)]. In a second cohort of 139 NPC patients followed-up for a median period of 2,027 days (interquartile range, 597-2,335 days), serum EBV DNA was found to be a significant variable associated with NPC-related death in multivariate Cox's regression analysis [relative risk = 1.6 (95% confidence interval, 1.1-2.1 for each 10-fold increase in serum EBV DNA concentration; P = 0.007)]. The quantitation of circulating EBV DNA may thus allow improved prognostication of NPC.
14
Y M Lo, Lisa Chan, Kwok Wai Lo et al. · PubMed · 1999 · 775 citations
Microsatellite alterations in serum DNA of head and neck cancer patients
Homaira Nawroz, Wayne M. Koch, Philippe Anker et al. · Nature Medicine · 1996 · 658 citations
Life Sciences, Genetics, Oncology +15
Microsatellite alterations in plasma DNA of small cell lung cancer patients
Xu Qi Chen, Maurice Stroun, Jean-Luc Magnenat et al. · Nature Medicine · 1996 · 654 citations
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
Ivy H.N. Wong, Yuk Ming Dennis Lo, Jingwan Zhang et al. · PubMed · 1999 · 519 citations